Preferential involvement of excitatory neurons in medial temporal lobe in schizophrenia

Lancet

Volumn 352, Issue 9141, 1998, Pages 1669-1673

  Harrison, Paul J ^a   Eastwood, Sharon L ^b  

^a WARNEFORD HOSPITAL   (United Kingdom)

^b RADCLIFFE INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEXIN 1; COMPLEXIN 2; MESSENGER RNA; PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; AUTOPSY; AUTORADIOGRAPHY; CEREBELLUM; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOARCHITECTURE; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MALE; NERVE CELL STIMULATION; PRIORITY JOURNAL; SCHIZOPHRENIA; SUBICULUM; SYNAPSE; TEMPORAL LOBE; TISSUE DISTRIBUTION;

EID: 0032556365     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(98)03341-8     Document Type: Article

References (28)

1. 1 Lawrie SM, Abukmeil SS. Brain abnormality in schizophrenia: a systematic and quantitative review of volumetric magnetic resonance imaging studies. Br J Psychiatry 1998; 172: 110-20.
2. 2 Arnold SE, Trojanowski JQ. Recent advances in defining the neuropathology of schizophrenia. Acta Neuropathol (Berl) 1996; 92: 217-31.
3. 3 Weinberger DR. Schizophrenia: from neuropathology to neurodevelopment. Lancet 1995; 346: 552-57.
4. 4 Benes FM, Sorensen I, Bird ED. Reduced neuronal size in posterior hippocampus of schizophrenic patients. Schizophr Bull 1991; 17: 597-608.
5. 5 Arnold SE, Franz BR, Gur RC, et al. Smaller neuron size in schizophrenia in hippocampal subfields that mediate cortical-hippocampal interactions. Am J Psychiatry 1995; 152: 738-48.
6. 6 Zaidel DW, Esiri MM, Harrison PJ. Size, shape, and orientation of neurons in the left and right hippocampus: investigation of normal asymmetries and alterations in schizophrenia. Am J Psychiatry 1997; 154: 812-18.
7. 7 Browning MD, Dudek EM, Rapier JL, Leonard S, Freedman R. Significant reductions in synapsin but not synaptophysin specific activity in the brains of some schizophrenics. Biol Psychiatry 1993; 34: 529-35.
8. 8 Eastwood SL, Burnet PWJ, Harrison PJ. Altered synaptophysin expression as a marker of synaptic pathology in schizophrenia. Neuroscience 1995; 66: 309-19.
9. 9 Eastwood SL, Harrison PJ. Decreased synaptophysin in the medial temporal lobe in schizophrenia demonstrated using immunoautoradiography. Neuroscience 1995; 69: 339-43.
10. 10 Young CE, Arima K, Xie J, et al. SNAP-25 deficit and hippocampal connectivity in schizophrenia. Cereb Cortex 1998; 8: 261-68.
11. 11 Arnold SE, Lee VM-Y, Gur RE, Trojanowski JQ. Abnormal expression of two microtubule-associated proteins (MAP2 and MAP5) in specific subfields of the hippocampal formation in schizophrenia. Proc Natl Acad Sci USA 1991; 88: 10850-54.
12. 12 Cotter D, Kerwin R, Doshi B, Martin CS, Everall IP. Alterations in hippocampal non-phosphorylated MAP2 protein expression in schizophrenia. Brain Res 1997; 765: 238-46.
13. 13 Deakin JFW, Slater P, Simpson MDC, et al. Frontal cortical and left temporal glutamatergic dysfunction in schizophrenia. J Neurochem 1989; 52: 1781-86.
14. 14 Harrison PJ, McLaughlin DP, Kerwin RW. Decreased hippocampal expression of a glutamate receptor gene in schizophrenia. Lancet 1991; 337: 450-52.
15. 15 Tsai GC, Passani LA, Slusher BS, et al. Abnormal excitatory neurotransmitter metabolism in schizophrenic brains. Arch Gen Psychiatry 1995; 52: 829-36.
16. 16 Porter RHP, Eastwood SL, Harrison PJ. Distribution of kainate receptor mRNAs in human hippocampus, neocortex and cerebellum, and bilateral reductions of hippocampal GluR6 and KA2 transcripts in schizophrenia. Brain Res 1997; 751: 217-31.
17. 17 Olney JW, Farber NB. Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry 1995; 52: 998-1007.
18. 18 McMahon HT, Missler M, Li C, Südhof TC. Complexins: cytosolic proteins that regulate SNAP receptor function. Cell 1995; 83: 111-19.
19. 19 Takahashi S, Yamamoto H, Matsuda Z, et al. Identification of two highly homologous presynaptic proteins distinctly localised at the dendritic and somatic synapses. FEBS Lett 1995; 368: 455-60.
20. 20 Peters A, Palay SL. The morphology of synapses. J Neurocytol 1996; 25: 687-700.
21. 21 Harrison PJ, Heath PR, Eastwood SL, Burnet PWJ, McDonald B, Pearson RCA. The relative importance of premortem acidosis and postmortem interval for human brain gene expression studies: selective mRNA vulnerability and comparison with their encoded proteins. Neurosci Lett 1995; 200: 151-54.
22. 22 Heckers S, Heinsen H, Geiger B, Beckmann H. Hippocampal neuron number in schizophrenia. Arch Gen Psychiatry 1991; 48: 1002-08.
23. 23 Zaidel DW, Esiri MM, Harrison PJ. The hippocampus in schizophrenia: lateralized increase in neuronal density and altered cytoarchitectural asymmetry. Psychol Med 1997; 27: 703-13.
24. 24 Krimer LS, Herman MM, Saunders RC, et al. A qualitative and quantitative analysis of the entorhinal cortex in schizophrenia. Cereb Cortex 1997; 7: 732-39.
25. 25 Gabriel SM, Haroutunian V, Powchik P, et al. Increased concentration of presynaptic proteins in the cingulate cortex of schizophrenics. Arch Gen Psychiatry 1997; 54: 559-66.
26. 26 Woo T-U, Whitehead RE, Melchitsky DS, Lewis DA. A subclass of prefrontal γ-aminobutyric acid axon terminals are selectively altered in schizophrenia. Proc Natl Acad Sci USA 1998; 95: 5341-46.
27. 27 Garey LJ, Ong WY, Patel TS, et al. Reduced dextritic spine density on cerebral cortical pyramidal neurons in schizophrenia. J Neurol Neurosurg Psychiatry 1998; 65: 446-53.
28. 28 McGuire PK, Frith CD. Disordered functional connectivity in schizophrenia. Psychol Med 1996; 26: 663-67.